SGLT2, ‘혈당 관계없이’ 당뇨 환자에 적극 사용 권고 SGLT2 Inhibitors Associated With Reduced Risk of Mortality, Hospitalization

Treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors was found to be associated with decreased risk of all-cause mortality and hospitalization in patients with type 2 diabetes (T2D), acc..

SGLT2, ‘혈당 관계없이’ 당뇨 환자에 적극 사용 권고 SGLT2 Inhibitors Associated With Reduced Risk of Mortality, Hospitalization에 대한 요약내용입니다.

자세한 내용은 아래에 원문링크를 확인해주시기 바랍니다.

원문링크 : SGLT2, ‘혈당 관계없이’ 당뇨 환자에 적극 사용 권고 SGLT2 Inhibitors Associated With Reduced Risk of Mortality, Hospitalization